/NDTP

NDTP Stock - NDT Pharmaceuticals Inc.

Q: What is the analyst price target for NDTP?

Analyst price target information is not currently available for NDTP.

Q: What is NDTP's market cap?

Market capitalization information is not currently available for NDTP.

Healthcare|Biotechnology|OTC

$1.75+16.67%

+$0.25 (+16.67%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

100

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $1.93

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for NDTP

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2015

FY2016

FY2017

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.00

52W High$2.10

52W Low$0.03

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2017	FY2016	FY2015
Revenue	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A
Gross Margin	N/A	N/A	N/A	N/A	N/A
Operating Income	$-16,691	$-25,170	$-1,240	$-1,930	$-87,330
Net Income	$-16,691	$-79,033	$-1,240	$-1,929	$-87,330
Net Margin	N/A	N/A	N/A	N/A	N/A
EPS	$-0.00	$-0.00	$-0.00	$-0.01	$-0.29

Company Overview

NDT Pharmaceuticals Inc., a biotechnology company, focuses on developing various therapies for severe neurological disorders associated with traumatic brain Injury. The company is based in Vienna, Virginia.

Visit Website

Earnings History & Surprises

NDTP

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$-4.43

Q2 2008

EPS Surprise History

Q3 06

No data

Q4 06

No data

Q2 07

No data

Q3 07

No data

Q4 07

No data

Q4 07

No data

Q1 08

No data

Q2 08

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2008	Jun 30, 2008	—	$-4.43	—	—
Q1 2008	Mar 30, 2008	—	$-0.52	—	—
Q4 2007	Dec 31, 2007	—	$-6.17	—	—
Q4 2007	Nov 14, 2007	—	$-0.43	—	—
Q3 2007	Aug 14, 2007	—	$2.00	—	—
Q2 2007	May 14, 2007	—	$-3.00	—	—
Q4 2006	Dec 31, 2006	—	$-0.50	—	—
Q3 2006	Sep 30, 2006	—	$-0.30	—	—
Q2 2006	Jun 30, 2006	—	$-0.14	—	—
Q1 2006	Mar 31, 2006	—	$-0.97	—	—

Frequently Asked Questions about NDTP

What is NDTP's current stock price?

NDT Pharmaceuticals Inc. (NDTP) is currently trading at $1.75 per share. The stock has moved +16.67% today.

What is the analyst price target for NDTP?

No analyst price targets are currently available for this stock.

What sector is NDT Pharmaceuticals Inc. in?

NDT Pharmaceuticals Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.

What is NDTP's market cap?

NDT Pharmaceuticals Inc. has a market capitalization of $0.28 billion, making it a small-cap company.

Does NDTP pay dividends?

No, NDT Pharmaceuticals Inc. does not currently pay a dividend to shareholders.